17 Einträge gefunden

1. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
2. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
3. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
4. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

   1. Minner, Sarah
   2. Hager, Dominik
   3. Steurer, Stefan
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Möller-Koop, Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
6. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
7. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
8. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
9. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

   1. Grupp, Katharina
   2. Boumesli, Rebecca
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
10. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

    1. Grupp, Katharina
    2. Ospina-Klinck, Daniel
    3. Tsourlakis, Maria Christina
    4. Koop, Christina
    5. Wilczak, Waldemar
    6. Adam, Meike
    7. Simon, Ronald

    2014 - Forschungsinformationssystem des UKE
11. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

    1. Jacobsen, Frank
    2. Ashtiani, Sharad Nouraie
    3. Tennstedt, Pierre
    4. Heinzer, Hans
    5. Simon, Ronald
    6. Sauter, Guido
    7. Sirma, Hüseyin

    2013 - Forschungsinformationssystem des UKE
12. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

    1. Sirma, Hüseyin
    2. Broemel, Margarethe
    3. Stumm, Laura
    4. Tsourlakis, Maria Christina
    5. Steurer, Stefan
    6. Tennstedt, Pierre
    7. Salomon, Georg

    2013 - Forschungsinformationssystem des UKE
13. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

    1. Tsourlakis, Maria Christina
    2. Schoop, Michael
    3. Plaß, Christoph
    4. Huland, Hartwig
    5. Graefen, Markus
    6. Steuber, Thomas
    7. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE
14. High mitochondria content is associated with prostate cancer disease progression

    1. Grupp, Katharina
    2. Jedrzejewska, Karolina
    3. Tsourlakis, Maria Christina
    4. Koop, Christina
    5. Wilczak, Waldemar
    6. Adam, Meike
    7. Quaas, Alexander

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
15. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma

    1. Clauditz, Till
    2. Gontarewicz, Artur
    3. Wang, Chia-Jung
    4. Münscher, Adrian
    5. Laban, Simon
    6. Tsourlakis, Maria Christina
    7. Knecht, Rainald

    2012 - Forschungsinformationssystem des UKE
16. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

    1. Clauditz, Till
    2. Gontarewicz, Artur
    3. Lebok, Patrick
    4. Tsourlakis, Maria Christina
    5. Grob, Tobias
    6. Münscher, Adrian
    7. Sauter, Guido

    2012 - Forschungsinformationssystem des UKE
17. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

    1. Clauditz, Till
    2. Reiff, Maren
    3. Gravert, Linn
    4. Gnoss, Alexander
    5. Tsourlakis, Maria Christina
    6. Münscher, Adrian
    7. Sauter, Guido

    2011 - Forschungsinformationssystem des UKE